Powder: -20°C for 3 years
In solvent: -80°C for 2 years
WHI-P180 is a potent <a href="/target/EGFR" style="display: inline; color: #c13a36">EGFR</a> and <a href="/target/CDK" style="display: inline; color: #c13a36">CDK</a>2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 159.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 373.00 | |
50 mg | In stock | $ 879.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 258.00 |
Description | WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively. |
Targets&IC50 | EGFR:4.0μM, CDK2:1.0 μM |
Synonyms | Janex 3 |
Molecular Weight | 297.314 |
Formula | C16H15N3O3 |
CAS No. | 211555-08-7 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 10 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
WHI-P180 211555-08-7 Angiogenesis Apoptosis Cell Cycle/Checkpoint JAK/STAT signaling Tyrosine Kinase/Adaptors VEGFR EGFR c-RET CDK WHI-P-180 HER1 Janex3 WHI P180 RET Vascular endothelial growth factor receptor Inhibitor Janex-3 WHIP180 Janex 3 inhibit ErbB-1 Epidermal growth factor receptor inhibitor